# Efficacy of Non-invasive Neuromodulation Treatments for COVID-19 Sequelae

> **NCT06544395** · NA · NOT_YET_RECRUITING · sponsor: **Clinica Gema Leon** · enrollment: 104 (estimated)

## Conditions studied

- Covid-19 Recurrent

## Interventions

- **DEVICE:** Non invasive neuromodulation therapy
- **OTHER:** Manual therapy
- **DEVICE:** Placebo with non invasive neuromodulation

## Key facts

- **NCT ID:** NCT06544395
- **Lead sponsor:** Clinica Gema Leon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-30
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06544395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06544395, "Efficacy of Non-invasive Neuromodulation Treatments for COVID-19 Sequelae". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06544395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*